top of page

REPAGLINIDE MEVON TABLETS 2 MG

Product details

Registration number: SIN16374P

Classification: Prescription Only

Active ingredients: Repaglinide

Strength: 2.0 mg

Dosage form: TABLET

Route: ORAL

Registrant: NOVEM PHARMA PRIVATE LIMITED

ATC code: A10BX02

HSA approval date: 12 November 2021

Manufacturer(s): Pharmathen S.A.

Manufacturing country/countries: GREECE

What are the HSA registration number and classification for REPAGLINIDE MEVON TABLETS 2 MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16374P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for REPAGLINIDE MEVON TABLETS 2 MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Repaglinide

Strength: 2.0 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for REPAGLINIDE MEVON TABLETS 2 MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET

Route: ORAL

Source for this answer

Who is the recorded registrant for REPAGLINIDE MEVON TABLETS 2 MG?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVEM PHARMA PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for REPAGLINIDE MEVON TABLETS 2 MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Pharmathen S.A.

Manufacturing country/countries: GREECE

Source for this answer

Where can I look up REPAGLINIDE MEVON TABLETS 2 MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16374P or the exact product name REPAGLINIDE MEVON TABLETS 2 MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this REPAGLINIDE MEVON TABLETS 2 MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this REPAGLINIDE MEVON TABLETS 2 MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16374P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page